Boston, April 01, 2026 (GLOBE NEWSWIRE) -- The global market for cloud computing in cell biology, genomics and drug development is projected to grow from $6.2 billion in 2024 to $15.6 billion by 2030, reflecting a compound annual growth rate (CAGR) of 16.7%, according to a new report from BCC Research.
The report, Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets, provides detailed analysis of the platforms, services and applications driving cloud adoption across the life sciences research and pharmaceutical development value chain.
Key Findings
- The market will reach $15.6 billion by 2030, growing at a robust 16.7% CAGR — one of the fastest growth rates in life sciences technology infrastructure — driven by the exponential increase in biological data generation and the need for scalable computational resources.
- North America leads with 44.7% market share, reflecting the region's concentration of pharmaceutical R&D activity, genomics research institutions and cloud infrastructure investment.
- The biological data explosion is the primary growth catalyst. Next-generation sequencing, single-cell omics, spatial transcriptomics and high-content imaging are generating datasets that far exceed the capacity of traditional on-premises computing infrastructure.
- AI and advanced analytics integration is accelerating cloud adoption, as machine learning workflows for drug target identification, molecular simulation and clinical trial optimization require elastic cloud computing resources and specialized GPU/TPU infrastructure.
- Cloud-native bioinformatics SaaS platforms are reshaping the competitive landscape, enabling smaller biotech firms and academic laboratories to access enterprise-grade computational capabilities without massive capital expenditure on IT infrastructure.
- Key players span cloud hyperscalers and life sciences specialists, including Alphabet/Google, Amazon Web Services, Benchling, Cisco, Cognizant, DNAnexus, IBM, Microsoft, Oracle, Rescale, Salesforce and SAP.
Market Drivers
The market is being propelled by several converging forces. The sheer volume of biological data being generated — from genomics, proteomics, metabolomics and imaging — is growing exponentially and demands scalable cloud infrastructure. Decentralized R&D models, accelerated by the pandemic, have made cloud collaboration platforms essential rather than optional. The integration of AI/ML into drug discovery pipelines requires computational elasticity that only cloud platforms can deliver. And regulatory frameworks are evolving to accommodate cloud-based data management in regulated life sciences environments.
Investment Considerations
Cloud computing infrastructure for life sciences represents a structural growth opportunity as the industry transitions from on-premises to cloud-native workflows. The 16.7% CAGR reflects both the early stage of cloud adoption in many life sciences organizations and the accelerating data-generation trends that make cloud migration increasingly necessary. Companies offering specialized life sciences cloud platforms — particularly those integrating AI capabilities and regulatory compliance — are positioned for sustained growth.
About the Report
Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets provides comprehensive market sizing, segmentation by service model, application area and geography, competitive intelligence, technology assessment and strategic forecasting through 2030.
For more information or to download the report, visit https://www.bccresearch.com/market-research/biotechnology/cloud-computing-for-cell-biology-genomics-market-report.html
About BCC Research
BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process.
BCC Research LLC 50 Milk St., Ste. 16, Boston, MA 02109 press@bccresearch.com | +1 781-489-7301 www.bccresearch.com
